Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis.

@article{Sabbagh2017IntratympanicDI,
  title={Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis.},
  author={Nagi G El Sabbagh and Maida J. Sewitch and Aren Bezdjian and Sam Joseph Daniel},
  journal={The Laryngoscope},
  year={2017},
  volume={127 8},
  pages={1897-1908}
}
OBJECTIVE Systemic dexamethasone has demonstrated conclusive benefits in reversing sudden sensorineural hearing loss (SSNHL) despite considerable number of potential side effects. In contrast, the intratympanic route of steroid administration averts several possible complications. This study aims to examine the literature to delineate the efficacy and side effect of intratympanic dexamethasone (ITD) injection for the treatment of SSNHL. DATA SOURCE Cochrane, Embase, and MEDLINE electronic… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

International consensus (ICON) on treatment of sudden sensorineural hearing loss.

European annals of otorhinolaryngology, head and neck diseases • 2018

Similar Papers

Loading similar papers…